The drug warfarin is a vitamin K antagonist that inhibits vitamin K epoxide reductase, interfering
with the reduction of the epoxide and halting the cycling back to the hydroquinone intermediate,
thereby interrupting the activation of blood coagulation factors [9–11]. Other vitamin K-dependent